A global Microsoft outage is currently affecting access to several systems, including the Patient Portal, Epic Care Link, and laboratory services. Teams are actively monitoring the situation and will share updates as more information becomes available. If your scheduled appointment was affected, please contact your healthcare team.
Akeem Lewis, M.D.
Hematology (Blood), Oncology (Cancer)
Appointment Information
Albert Lea, MN
Hospital and Clinic
404 W. Fountain St., Albert Lea, MN 56007Provider's Bio
I am deeply committed to patient-centered care with a strong focus on education and open communication through a foundation of evidence-based medicine.
I believe when you are well-informed about your condition and treatment options, you can make the best decisions for your unique situation. By fostering a supportive environment and providing personalized information, I will strive to empower you and help you feel in control of your journey.
Training & Credentials
Education
- St. George's University School of Medicine
Residencies
- Internal Medicine, State University of New York Downstate Medical Center
- Internal Medicine, Memorial Sloan-Kettering Cancer Center
Fellowship
- Hematology/Oncology, Mayo Clinic School of Graduate Medical Education
Certification
- Internal Medicine, American Board of Internal Medicine
Memberships
- Alpha Omega Alpha Honor Medical Society
- American Society of Clinical Oncology
- American Society of Clinical Oncology Trainee and Early Career Advisory Group
- American Society of Hematology
Academic Appointments
- Instructor in Medicine, Mayo Clinic College of Medicine and Science
- Instructor in Oncology Mayo Clinic College of Medicine and Science
Special Interests
- Bladder cancer
- General oncology
- Global oncology
- Health care delivery
- Hematology
- Immunotherapy
- Kidney cancer
- Medical education
- Prostate cancer
- Targeted therapy
- Testicular cancer
Research & Publications
- Role of individual factor X concentrate pharmacokinetic studies in perioperative management of AL amyloidosis-associated acquired factor X deficiency, July 2023.
- A review of theranostics: Perspectives on emerging approaches and clinical advancements, July 2023.
- Dynamic assessment of serum chromogranin A and treatment response with abiraterone acetate in metastatic castration-resistant prostate cancer, May 2023.
- Outcomes of second-line therapies in patients with metastatic de Novo and treatment-emergent neuroendocrine prostate cancer: A multi-institutional study, April 2023.
- Acquired factor VIII deficiency in prostate adenocarcinoma presenting as multiple hematomas and hemarthrosis, February 2020.